New recombinant producer of human ω-amidase based on Escherichia coli
- Authors: Krasnikov B.F.1, Deryabina Y.I.1, Isakova E.P.1, Biriukova I.K.2, Shevelev A.B.2, Antipov A.N.1
-
Affiliations:
- Bach Institute of Biochemistry, Research Center of Biotechnology
- Emanuel Institute of Biochemical Physics
- Issue: Vol 53, No 3 (2017)
- Pages: 290-295
- Section: Article
- URL: https://journal-vniispk.ru/0003-6838/article/view/152223
- DOI: https://doi.org/10.1134/S0003683817030115
- ID: 152223
Cite item
Abstract
A new artificial gene encoding human ω-amidase (Nit2) adapted for highly efficient expression in E. coli has been established. A pQE-Nit2 plasmid construct controlled by the T5 promoter has been engineered for its expression. The nit2 gene within the pQE-Nit2 construct has optimized codon usage and an artificial 6His-tag sequence inserted directly after the ATG initiation codon. This tag provides the possibility of single-step purification of a product via metal chelate chromatography. The codon-usage optimization involves the inclusion of several codons of extremely rare occurrence in natural E. coli ORFs within a 30 a.a-long N-terminal region. Other codons included in the N-terminus have moderate occurrence in E. coli. The subsequent sequence of the artificial gene has been composed of the most frequently occurring codons in E. coli. The recombinant producer based on the pQE-Nit2 construct allowed purification of the enzyme with an activity of 6.2 ± 0.2 μmol/min/mg protein, which corresponds to or slightly exceeds the specific activity of rat liver Nit2. The omega-amidase preparation is necessary for the screening of potential inhibitors that can be used as candidate drugs to cure hyperammonemia disorders in liver pathologies and oncological diseases.
Keywords
About the authors
B. F. Krasnikov
Bach Institute of Biochemistry, Research Center of Biotechnology
Email: yul_der@mail.rus
Russian Federation, Moscow, 119071
Yu. I. Deryabina
Bach Institute of Biochemistry, Research Center of Biotechnology
Author for correspondence.
Email: yul_der@mail.rus
Russian Federation, Moscow, 119071
E. P. Isakova
Bach Institute of Biochemistry, Research Center of Biotechnology
Email: yul_der@mail.rus
Russian Federation, Moscow, 119071
Iu. K. Biriukova
Emanuel Institute of Biochemical Physics
Email: yul_der@mail.rus
Russian Federation, Moscow, 119334
A. B. Shevelev
Emanuel Institute of Biochemical Physics
Email: yul_der@mail.rus
Russian Federation, Moscow, 119334
A. N. Antipov
Bach Institute of Biochemistry, Research Center of Biotechnology
Email: yul_der@mail.rus
Russian Federation, Moscow, 119071
Supplementary files
